- call +1-201-465-4211
- email sales@mrinsights.biz
Type 2 diabetes is a progressive condition in which the body becomes resistant to the normal effects of insulin and/or gradually loses the capacity to produce enough insulin in the pancreas. We do not know what causes type 2 diabetes. Type 2 diabetes is associated with modifiable lifestyle risk factors. Type 2 diabetes also has strong genetic and family related risk factors.
Scope of the Report:
This report focuses on the Type 2 Diabetes in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The dramatic increase in the prevalence, progressive nature and diagnosis of type 2 diabetes is the main driver of this rapid growth rate. The rise in disease-related comorbidities has also fuelled a more aggressive approach to treatment, including the use of multiple-drug therapies.
The Americas dominated the global type 1 diabetes drug market and accounted for close to 50% of the global type 1 diabetes market size. The US was the largest revenue contributor to the diabetes drug market in this region because of the growing prevalence of the disease and rise in obesity. The accessibility to therapies by reimbursement programs is further expected to drive the growth of the diabetes drug market size in the Americas.
The worldwide market for Type 2 Diabetes is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Novo Nordisk
Sanofi
Merck
Eli Lily
AstraZeneca
Astellas Pharma
Daiichi Sankyo
Biocon
Boehringer Ingelheim
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Insulins
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT-2 Inhibitors
Market Segment by Applications, can be divided into
Drugstore
Hospital
Others
There are 15 Chapters to deeply display the global Type 2 Diabetes market.
Chapter 1, to describe Type 2 Diabetes Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Type 2 Diabetes, with sales, revenue, and price of Type 2 Diabetes, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Type 2 Diabetes, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Type 2 Diabetes market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Type 2 Diabetes sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Type 2 Diabetes Introduction
1.2 Market Analysis by Type
1.2.1 Insulins
1.2.2 DPP-4 Inhibitors
1.2.3 GLP-1 Receptor Agonists
1.2.4 SGLT-2 Inhibitors
1.3 Market Analysis by Applications
1.3.1 Drugstore
1.3.2 Hospital
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Business Overview
2.1.2 Type 2 Diabetes Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novo Nordisk Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Type 2 Diabetes Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 Type 2 Diabetes Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lily
2.4.1 Business Overview
2.4.2 Type 2 Diabetes Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lily Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 AstraZeneca
2.5.1 Business Overview
2.5.2 Type 2 Diabetes Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AstraZeneca Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Astellas Pharma
2.6.1 Business Overview
2.6.2 Type 2 Diabetes Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Astellas Pharma Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Daiichi Sankyo
2.7.1 Business Overview
2.7.2 Type 2 Diabetes Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Daiichi Sankyo Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Biocon
2.8.1 Business Overview
2.8.2 Type 2 Diabetes Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biocon Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Boehringer Ingelheim
2.9.1 Business Overview
2.9.2 Type 2 Diabetes Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Boehringer Ingelheim Type 2 Diabetes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Type 2 Diabetes Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Type 2 Diabetes Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Type 2 Diabetes Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Type 2 Diabetes Manufacturer Market Share in 2017
3.3.2 Top 6 Type 2 Diabetes Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Type 2 Diabetes Market Analysis by Regions
4.1 Global Type 2 Diabetes Sales, Revenue and Market Share by Regions
4.1.1 Global Type 2 Diabetes Sales and Market Share by Regions (2013-2018)
4.1.2 Global Type 2 Diabetes Revenue and Market Share by Regions (2013-2018)
4.2 North America Type 2 Diabetes Sales and Growth Rate (2013-2018)
4.3 Europe Type 2 Diabetes Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Type 2 Diabetes Sales and Growth Rate (2013-2018)
4.5 South America Type 2 Diabetes Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Type 2 Diabetes Sales and Growth Rate (2013-2018)
5 North America Type 2 Diabetes by Countries
5.1 North America Type 2 Diabetes Sales, Revenue and Market Share by Countries
5.1.1 North America Type 2 Diabetes Sales and Market Share by Countries (2013-2018)
5.1.2 North America Type 2 Diabetes Revenue and Market Share by Countries (2013-2018)
5.2 United States Type 2 Diabetes Sales and Growth Rate (2013-2018)
5.3 Canada Type 2 Diabetes Sales and Growth Rate (2013-2018)
5.4 Mexico Type 2 Diabetes Sales and Growth Rate (2013-2018)
6 Europe Type 2 Diabetes by Countries
6.1 Europe Type 2 Diabetes Sales, Revenue and Market Share by Countries
6.1.1 Europe Type 2 Diabetes Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Type 2 Diabetes Revenue and Market Share by Countries (2013-2018)
6.2 Germany Type 2 Diabetes Sales and Growth Rate (2013-2018)
6.3 UK Type 2 Diabetes Sales and Growth Rate (2013-2018)
6.4 France Type 2 Diabetes Sales and Growth Rate (2013-2018)
6.5 Russia Type 2 Diabetes Sales and Growth Rate (2013-2018)
6.6 Italy Type 2 Diabetes Sales and Growth Rate (2013-2018)
7 Asia-Pacific Type 2 Diabetes by Countries
7.1 Asia-Pacific Type 2 Diabetes Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Type 2 Diabetes Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Type 2 Diabetes Revenue and Market Share by Countries (2013-2018)
7.2 China Type 2 Diabetes Sales and Growth Rate (2013-2018)
7.3 Japan Type 2 Diabetes Sales and Growth Rate (2013-2018)
7.4 Korea Type 2 Diabetes Sales and Growth Rate (2013-2018)
7.5 India Type 2 Diabetes Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Type 2 Diabetes Sales and Growth Rate (2013-2018)
8 South America Type 2 Diabetes by Countries
8.1 South America Type 2 Diabetes Sales, Revenue and Market Share by Countries
8.1.1 South America Type 2 Diabetes Sales and Market Share by Countries (2013-2018)
8.1.2 South America Type 2 Diabetes Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Type 2 Diabetes Sales and Growth Rate (2013-2018)
8.3 Argentina Type 2 Diabetes Sales and Growth Rate (2013-2018)
8.4 Colombia Type 2 Diabetes Sales and Growth Rate (2013-2018)
9 Middle East and Africa Type 2 Diabetes by Countries
9.1 Middle East and Africa Type 2 Diabetes Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Type 2 Diabetes Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Type 2 Diabetes Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Type 2 Diabetes Sales and Growth Rate (2013-2018)
9.3 UAE Type 2 Diabetes Sales and Growth Rate (2013-2018)
9.4 Egypt Type 2 Diabetes Sales and Growth Rate (2013-2018)
9.5 Nigeria Type 2 Diabetes Sales and Growth Rate (2013-2018)
9.6 South Africa Type 2 Diabetes Sales and Growth Rate (2013-2018)
10 Global Type 2 Diabetes Market Segment by Type
10.1 Global Type 2 Diabetes Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Type 2 Diabetes Sales and Market Share by Type (2013-2018)
10.1.2 Global Type 2 Diabetes Revenue and Market Share by Type (2013-2018)
10.2 Insulins Sales Growth and Price
10.2.1 Global Insulins Sales Growth (2013-2018)
10.2.2 Global Insulins Price (2013-2018)
10.3 DPP-4 Inhibitors Sales Growth and Price
10.3.1 Global DPP-4 Inhibitors Sales Growth (2013-2018)
10.3.2 Global DPP-4 Inhibitors Price (2013-2018)
10.4 GLP-1 Receptor Agonists Sales Growth and Price
10.4.1 Global GLP-1 Receptor Agonists Sales Growth (2013-2018)
10.4.2 Global GLP-1 Receptor Agonists Price (2013-2018)
10.5 SGLT-2 Inhibitors Sales Growth and Price
10.5.1 Global SGLT-2 Inhibitors Sales Growth (2013-2018)
10.5.2 Global SGLT-2 Inhibitors Price (2013-2018)
11 Global Type 2 Diabetes Market Segment by Application
11.1 Global Type 2 Diabetes Sales Market Share by Application (2013-2018)
11.2 Drugstore Sales Growth (2013-2018)
11.3 Hospital Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Type 2 Diabetes Market Forecast (2018-2023)
12.1 Global Type 2 Diabetes Sales, Revenue and Growth Rate (2018-2023)
12.2 Type 2 Diabetes Market Forecast by Regions (2018-2023)
12.2.1 North America Type 2 Diabetes Market Forecast (2018-2023)
12.2.2 Europe Type 2 Diabetes Market Forecast (2018-2023)
12.2.3 Asia-Pacific Type 2 Diabetes Market Forecast (2018-2023)
12.2.4 South America Type 2 Diabetes Market Forecast (2018-2023)
12.2.5 Middle East and Africa Type 2 Diabetes Market Forecast (2018-2023)
12.3 Type 2 Diabetes Market Forecast by Type (2018-2023)
12.3.1 Global Type 2 Diabetes Sales Forecast by Type (2018-2023)
12.3.2 Global Type 2 Diabetes Market Share Forecast by Type (2018-2023)
12.4 Type 2 Diabetes Market Forecast by Application (2018-2023)
12.4.1 Global Type 2 Diabetes Sales Forecast by Application (2018-2023)
12.4.2 Global Type 2 Diabetes Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Type 2 Diabetes Picture
Table Product Specifications of Type 2 Diabetes
Figure Global Sales Market Share of Type 2 Diabetes by Types in 2017
Table Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
